Analyst Ratings for Rhythm Pharmaceuticals (RYTM) [Neutrals]

RYTM Rating Summary

RYTM Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RYTM
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $50.75 (+135%) * Over Last 12-Mos
Rating Score: 7.5 / 10   Percentile Rank: 78%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/30/2020 BofA Securities
» Updated 1/27/2021
Tazeen Ahmad Downgrade Neutral
(Buy)
35.00
(33.00)
29.27
(21.60)
-26.2% Details
Like RYTM Ratings? Also take a look at GMDA, PEG

RYTM Ratings News